Improving Health Care Infrastructure and Practices
By doing our part to help improve local healthcare infrastructure, we help create and support an environment where medical practices can deliver the most innovative treatments to patients.
We train healthcare professionals in Good Clinical Practices (GCP) through national and regional hubs operated by our R&D Global Centers of Excellence, as well as through the groundbreaking efforts of the Bristol-Myers Squibb Foundation’s Technical Assistance Program in Africa. Similar efforts are also underway in Turkey, Latin America and the United Arab Emirates.
Global Centers of Excellence: Bristol-Myers Squibb’s R&D organization has trained local healthcare professionals in Good Clinical Practices (GCP) in developing nations including India and Brazil in an effort to strengthen the local healthcare infrastructure and clinical trial activities. There are 17 such national and regional hubs worldwide. Bristol-Myers Squibb has partnered with the Duke Translational Medicine Institute for some of these efforts.
DIFAR: This Latin American focused educational program teaches general healthcare practitioners how to better prevent, diagnose and treat type 2 diabetes. Practitioners learn how to identify the main risk factors and mitigate the progression of chronic complications associated with the disease.
Breaking the Barriers in Diabetes: This program in the United Arab Emirates (UAE) strives to develop sustainable partnerships to improve the educational level of general practitioners in treating the disease, which is a major health issue in the UAE.
Hematology in Turkey: A specially developed website for chronic myelogenous leukemia (CML) – www.bmsonkoloji.com – provides data and scientific information to healthcare providers. The site also allows physicians to send medical information requests and adverse event reports to the company.
A compact disc (CD), “CURE,” has also been used for healthcare professionals in Turkey. Covering all hematologic diseases, its resources include diagnosis criteria, recent data and treatment options. Hematologists and oncologists were also offered a web platform for three months – called “e-Oncology Days” – in late 2011 to provide educational sessions on HCC (hepatocellular carcinoma), melanoma and CML.